Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.
G197del is the most prevalent LDL receptor (LDLR) mutation causing familial hypercholesterolemia (FH) in Ashkenazi Jew (AJ) individuals. The purpose of this study was to determine the origin, age, and population distribution of G197del, as well as to explore environmental and genetic effects on disease expression. Index cases from Israel (n=46), South Africa (n=24), Russia (n=7), The Netherlands (n=1), and the United States (n=1) were enlisted. All trace their ancestry to Lithuania. A highly conserved haplotype (D19S221:104-D19S865:208-D19S413:74) was identified in G197del chromosomes, suggesting the occurrence of a common founder. When two methods were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus and for the study of the decay of LD over time, the estimated age of the deletion was found to be 20 +/- 7 generations (the 95% confidence interval is 15-26 generations), so that the most recent common ancestor of the mutation-bearing chromosomes would date to the 14th century. This corresponds with the founding of the Jewish community of Lithuania (1338 a.d.), as well as with the great demographic expansion of AJ individuals in eastern Europe, which followed this settlement. The penetrance of mutation-linked severe hypercholesterolemia is high (94% of heterozygotes have a baseline concentration of LDL cholesterol (LDL-C) that is >160 mg/dl), and no significant differences in the mean baseline lipid level of G197del carriers from different countries were found. Polymorphisms of apolipoprotein E and of scavenger-receptor class B type I were observed to have minor effects on the plasma lipid profile. With respect to determinative genetic influences on the biochemical phenotype, there is no evidence that could support the possibility of a selective evolutionary metabolic advantage. Therefore, the founder effect in a rapidly expanding population from a limited number of families remains a simple, parsimonious hypothesis explaining the spread of G197del-LDLR-linked FH in AJ individuals.
Durst
R
R
Division of Medicine and the Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah University Hospital, 91120 Jerusalem, Israel.
Colombo
R
R
Shpitzen
S
S
Avi
L B
LB
Friedlander
Y
Y
Wexler
R
R
Raal
F J
FJ
Marais
D A
DA
Defesche
J C
JC
Mandelshtam
M Y
MY
Kotze
M J
MJ
Leitersdorf
E
E
Meiner
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D001057:Apolipoproteins E / Q000235:genetics; D018955:CD36 Antigens / Q000235:genetics; D002648:Child; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics; D005260:Female; D018703:Founder Effect; D005787:Gene Frequency / Q000235:genetics; D018740:Genetic Heterogeneity; D006239:Haplotypes; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000453:epidemiology* / Q000235:genetics*; D015994:Incidence; D007585:Jews / Q000235:genetics*; D015810:Linkage Disequilibrium / Q000235:genetics; D008097:Lithuania / Q000208:ethnology; D008297:Male; D008565:Membrane Proteins; D008875:Middle Aged; D008957:Models, Genetic; D019683:Penetrance; D011110:Polymorphism, Genetic / Q000235:genetics; D011971:Receptors, Immunologic; D011973:Receptors, LDL / Q000235:genetics; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D017384:Sequence Deletion / Q000235:genetics*
D001057:Apolipoproteins E; D018955:CD36 Antigens; D008565:Membrane Proteins; D011971:Receptors, Immunologic; D011973:Receptors, LDL; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C495124:SCARB1 protein, human; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B